CA2030346A1 - Traitement de troubles cardiaques a l'aide de composes de 15-ceto-prostaglandines - Google Patents

Traitement de troubles cardiaques a l'aide de composes de 15-ceto-prostaglandines

Info

Publication number
CA2030346A1
CA2030346A1 CA2030346A CA2030346A CA2030346A1 CA 2030346 A1 CA2030346 A1 CA 2030346A1 CA 2030346 A CA2030346 A CA 2030346A CA 2030346 A CA2030346 A CA 2030346A CA 2030346 A1 CA2030346 A1 CA 2030346A1
Authority
CA
Canada
Prior art keywords
treatment
keto
cardiac dysfunction
prostaglandin compounds
prostaglandin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2030346A
Other languages
English (en)
Other versions
CA2030346C (fr
Inventor
Ryuji Ueno
Hiroyoshi Osama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sucampo GmbH
Original Assignee
Ueno Seiyaku Oyo Kenkyujo KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ueno Seiyaku Oyo Kenkyujo KK filed Critical Ueno Seiyaku Oyo Kenkyujo KK
Publication of CA2030346A1 publication Critical patent/CA2030346A1/fr
Application granted granted Critical
Publication of CA2030346C publication Critical patent/CA2030346C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002030346A 1989-11-22 1990-11-20 Traitement de troubles cardiaques a l'aide de composes de 15-ceto-prostaglandines Expired - Fee Related CA2030346C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP30384089 1989-11-22
JP303840/1989 1989-11-22

Publications (2)

Publication Number Publication Date
CA2030346A1 true CA2030346A1 (fr) 1991-05-23
CA2030346C CA2030346C (fr) 2000-04-11

Family

ID=17925938

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002030346A Expired - Fee Related CA2030346C (fr) 1989-11-22 1990-11-20 Traitement de troubles cardiaques a l'aide de composes de 15-ceto-prostaglandines

Country Status (9)

Country Link
EP (1) EP0430551B1 (fr)
JP (1) JPH0791191B2 (fr)
KR (1) KR0167557B1 (fr)
AT (1) ATE162717T1 (fr)
CA (1) CA2030346C (fr)
DE (1) DE69032000T2 (fr)
DK (1) DK0430551T3 (fr)
ES (1) ES2113345T3 (fr)
GR (1) GR3026105T3 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU739343B2 (en) * 1997-11-28 2001-10-11 Sucampo Ag Endothelin antagonist
BRPI0014869B8 (pt) 1999-10-15 2021-05-25 Sucampo Ag prostaglandinas bicíclicas, composições estabilizadas das mesmas, bem como processo para sua estabilização
US6414016B1 (en) * 2000-09-05 2002-07-02 Sucampo, A.G. Anti-constipation composition
AR037524A1 (es) * 2001-11-14 2004-11-17 Sucampo Ag Unidad de dosificacion que comprende un analogo de prostaglandina para el tratamiento de la constipacion
TWI263505B (en) 2001-11-19 2006-10-11 Sucampo Ag Pharmaceutical composition comprising a C1C-2 channel opener
KR100804525B1 (ko) 2005-03-24 2008-02-20 삼성에스디아이 주식회사 집적회로 칩용 방열부재 및 이를 구비한 디스플레이 모듈
WO2009104205A1 (fr) * 2008-02-20 2009-08-27 Lupin Limited Formulation à libération retardée d’un activateur du canal chlorure
CN102028696B (zh) * 2009-09-24 2013-02-13 上海天伟生物制药有限公司 一种前列腺素类化合物的用途
US10457623B1 (en) 2018-07-13 2019-10-29 Chirogate International Inc. Process for the preparation of Lubiprostone and intermediates thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2328132A1 (de) * 1973-05-30 1975-01-02 Schering Ag Neue prostansaeurederivate und verfahren zu ihrer herstellung
JPS581117B2 (ja) * 1976-01-01 1983-01-10 フアイザ−・インコ−ポレ−テツド １１−デオキシ−ω−ペンタノルプロスタグランジン類
JPS5879973A (ja) * 1981-11-09 1983-05-13 Ono Pharmaceut Co Ltd プロスタグランジン誘導体の重合体、その製造方法及び該重合体を有効成分として含有する治療剤
JPS60208917A (ja) * 1984-02-29 1985-10-21 ジ・アツプジヨン・カンパニー Ａｒｄｓおよび多器官不全治療、予防におけるプロスタグランジンの使用
EP0153858A3 (fr) * 1984-02-29 1985-12-11 The Upjohn Company Application thérapeutique de prostaglandines
JP2597629B2 (ja) * 1988-02-26 1997-04-09 株式会社 上野製薬応用研究所 １３，１４−ジヒドロ−１５−ケトプロスタグランジン類の安定化
JP2597649B2 (ja) * 1988-05-11 1997-04-09 株式会社上野製薬応用研究所 気管・気管支拡張剤
EP0343904B1 (fr) * 1988-05-23 1993-04-28 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Composition provoquant l'hypersphyxie
JP2760514B2 (ja) * 1988-07-20 1998-06-04 株式会社 上野製薬応用研究所 循環機能昂進剤

Also Published As

Publication number Publication date
CA2030346C (fr) 2000-04-11
KR0167557B1 (ko) 1999-01-15
JPH03218314A (ja) 1991-09-25
ATE162717T1 (de) 1998-02-15
EP0430551B1 (fr) 1998-01-28
ES2113345T3 (es) 1998-05-01
GR3026105T3 (en) 1998-05-29
KR910009270A (ko) 1991-06-28
EP0430551A3 (en) 1992-07-15
JPH0791191B2 (ja) 1995-10-04
EP0430551A2 (fr) 1991-06-05
DE69032000D1 (de) 1998-03-05
DE69032000T2 (de) 1998-05-14
DK0430551T3 (da) 1998-04-14

Similar Documents

Publication Publication Date Title
DK0379979T3 (fr)
EP0427247A3 (en) Pharmaceutical composition with r-alpha-lipoic acid or s-alpha-lipoic acid as the active ingredient
CA2030433A1 (fr) Derives d'acide amine
CA2024188A1 (fr) Methode de traitement de l'ejaculation prematuree a l'aide de la sertraline
CA2041417A1 (fr) Traitement d'une maladie du pancreas a l'aide de composes de 15-ceto-prostaglandine
CA2069608A1 (fr) Derives de substitution de 4-phenylpiperidine-4-carboxamides ayant des effets anesthesiques et analgesiques locaux; methode de preparation
CA2062653A1 (fr) Promotion de la cicatrisation avec des composes a base de 15-cetoprostaglandine
CA2029657A1 (fr) Compositions pharmaceutiques permettant de reduire la tension intra-oculaire et mode d'utilisation
CA2046069A1 (fr) Traitement des maladies inflammatoires au moyen de composes de 15-cetoprostaglandine
NZ232946A (en) Preparation of crystalline 17alpha-hydroxy-7alpha methyl-19-nor-17-pregn-5
CA2135614A1 (fr) Utilisation de l'urodilatine pour les affections pulmonaires et bronchiques
CA2179015A1 (fr) Utilisation de bis(amidinobenzimidazoles) dans la fabrication de medicaments destines a inhiber l'integrase retrovirale
GEP19971030B (en) Method for preparation of derivatives of 1-benzil-3-oximetil-indazolului or salts with pharmaceutically acceptable bases
CA2179733A1 (fr) Sulfamates de pseudofructopyranose anticonvulsifs
CA2027814A1 (fr) Traitement d'une maladie hepatobiliaire a base de composes 5-cetoprostaglandin
CA2042972A1 (fr) Traitement de l'hypertension oculaire au moyen d'une combinaison synergique pour administration oculaire
CA2030346A1 (fr) Traitement de troubles cardiaques a l'aide de composes de 15-ceto-prostaglandines
HUT51283A (en) Process for production of n-alkyl derivatives of bu-3608-antibiotics and medical compositions containing them as active substances
CA2042934A1 (fr) Traitement de l'hypertension oculaire au moyen d'une combinaison synergique oculaire
AU4897790A (en) (-)-N"-Cyano-N-3-pyridyl-N'-1,2,2-trimethyl- propylguanidine, a process for preparing the compound, and use of the compound as a medicament
CA2114859A1 (fr) Compose cytotoxique et antiviral
CA2030344A1 (fr) Traitement de troubles pulmonaires a l'aide de composes de 15-ceto-prostaglandines
CA2041240A1 (fr) Traitement biochimique a l'aide de 15-deshydroxy-16-oxoprostaglandine
CA2048245A1 (fr) Traitement de la cataracte avec des composes a base de prostacycline
EP0342423A3 (fr) Dérivés d'hétéroaroylhydrazides d'antibiotiques bêta-lactames monocycliques

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed